Skip to main content

Open Access Publications from the University of California

Search eScholarship

Refine Search

All of eScholarshipThis Series

UCSF

UC San Francisco Previously Published Works banner

Menu

About eScholarship
UC Open Access Policies
Journals
Dissertations
UCSF Academic Units
UCSF Home

eScholarship
UCSF
UC San Francisco Previously Published Works

This item is not available for download from eScholarship

Share

Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification

2016

Kampmann, Martin;
Gilbert, Luke;
Deans, RM;
Morgens, DW;
Okesli, A;
Pillay, S;
Horlbeck, MA;
Gilbert, LA;
Li, A;
Mateo, R;
Smith, M
et al.

Published Web Location

http://europepmc.org/articles/PMC4836973?pdf=render

No data is associated with this publication.

Item not freely available? Link broken?

Report a problem accessing this item

Related Items

Cisplatin shortage results in substitution of more expensive treatments: Drug cost analysis
Assessing patient burden and benefit: A decade of cabozantinib clinical trials
The Minimally-Invasive Oral Glucose Minimal Model: Estimation of Gastric Retention, Glucose Rate of Appearance, and Insulin Sensitivity From Type 1 Diabetes Data Collected in Real-Life Conditions.
TOPAS-imaging: extensions to the TOPAS simulation toolkit for medical imaging systems.
Safety of high-dose-rate brachytherapy in patients with prostate cancer and inflammatory bowel disease: A case series.

Home
About eScholarship
Campus Sites
UC Open Access Policy
eScholarship Publishing
Accessibility
Privacy Statement
Site Policies
Terms of Use
Admin Login
Help

Powered by the
California Digital Library
Copyright © 2017
The Regents of the University of California